Lataa...
Neonatal Safety Information Reported to the FDA During Drug Development Studies
BACKGROUND: Relatively few neonatal drug development studies have been conducted, but an increase is expected with the enactment of the Food and Drug Administration Safety and Innovation Act (FDASIA). Understanding the safety of drugs studied in neonates is complicated by the unique nature of the po...
Tallennettuna:
| Julkaisussa: | Ther Innov Regul Sci |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5549935/ https://ncbi.nlm.nih.gov/pubmed/28804696 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2168479017716713 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|